|
14:00
“Risk of acute liver injury following the nirmatrelvir/ritonavir use”
by Mr AU Chi Ho Ivan
14:20
“Development of peptide-based nucleic acid delivery systems with the microfluidic method”
by Mr MA Cheng
14:40
“Integrative omics identifies novel candidates for the treatment of osteoporosis”
by Mr KRISHNAMOORTHY Suhas
15:00
“Attention deficit hyperactivity disorder, physical abuse and methylphenidate treatment in children”
by Miss GAO Le
15:20
“Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: a self-controlled case series study”
by Mr FAN Min
15:40
“Hyperactivation of CDK5/P25 signalling in the endothelium causes diastolic cardiac dysfunction”
by Mr SINGH Sandeep
16:00
“Effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized COVID-19 patients: a target trial emulation study”
by Mr YAN Ka Chun Vincent
16:20
“The anticancer effect of water extract of Amauroderma rugosum on colon cancer cells”
by Miss ZHENG Chengwen
16:40
“Dual targeting powder formulation of SARS-CoV-2 neutralizing monoclonal antibody”
by Mr SEOW Han Cong
17:00
“Synergistic combination of D-LAK antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis”
by Miss SHAO Zitong
|
